Guangzhou Medprin Biomedical Technology Co., Ltd. announces that its proposed acquisition of 100% equity in Guangzhou Medi-Care Medical Technology Co., Ltd. and fundraising has been approved by the SZSE Merger and Acquisition Review Committee. The transaction is subject to registration approval from the China Securities Regulatory Commission.
Summary generated by AI · Always verify with source document
Guangzhou Medprin Biomedical Technology Co., Ltd.
Announcement on the Approval of the Company's Issuance of Shares and Payment of Cash to Purchase Assets and Raise Supporting Funds, and Related Transaction Matters by the SZSE Merger and Acquisition Review Committee
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.